Literature DB >> 6211328

Non-invasive investigation of vascular compression in patients with thoracic outlet syndrome.

J Sällström, O Thulesius.   

Abstract

Three hundred and seventy-seven patients with brachial pain and 63 controls have been examined regarding presence of symptomatic compression of the brachial plexus and subclavian vessels (Thoracic Outlet Syndrome = TOS). Each patient was examined clinically and by Doppler flowmetry. Two hundred and thirty (61%) had moderate to pronounced compression of the brachial plexus and 11 (2.9%) isolated compression of the subclavian artery or vein. One hundred and twenty-nine patients had symptoms not related to TOS. The prevalence of TOS was almost twice as common in women as in men, 1.76:1. The TOS patients were younger than the non-TOS patients, P less than 0.05. There was a significant correlation between arterial compression measured by Doppler flowmetry and the presence of compression of the plexus, P less than 0.001. But the validity of this method was not satisfactory, giving both false positive and negative results. Furthermore, there was a very good correlation between arterial compression assessed clinically and by Doppler flowmetry, P less than 0.001. Thus, the diagnosis of TOS is still a clinical judgement, the Doppler technique adding very little and any significant vascular compression being easily detected by clinical assessment.

Entities:  

Mesh:

Year:  1982        PMID: 6211328     DOI: 10.1111/j.1475-097x.1982.tb00014.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  2 in total

1.  Thoracic outlet syndrome.

Authors:  C V Ruckley
Journal:  Br Med J (Clin Res Ed)       Date:  1983-08-13

2.  Relationship Between Inflow Impairment and Skin Oxygen Availability to the Upper Limb During Standardized Arm Abduction in Patients With Suspected Thoracic Outlet Syndrome.

Authors:  Jeanne Hersant; Simon Lecoq; Pierre Ramondou; Xavier Papon; Mathieu Feuilloy; Pierre Abraham; Samir Henni
Journal:  Front Physiol       Date:  2022-02-11       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.